Glycated hemoglobin predicts mortality in nondiabetic patients receiving chronic peritoneal dialysis

American Journal of Nephrology

Volumn 32, Issue 6, 2010, Pages 567-574

  Chen, Kuan Hsing ^a,b   Lin, Ja Liang ^a,b   Lin Tan, Dan Tzu ^a,b   Hsu, Ching Wei ^a,b   Huang, Wen Hung ^a,b   Yen, Tzung Hai ^a,b   Weng, Shu Man ^a   Hung, Cheng Chieh ^a,b  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^b CHANG GUNG UNIVERSITY   (Taiwan)

Author keywords

Chronic peritoneal dialysis; Glycated hemoglobin; HbA1c; Mortality; Nondiabetes

Indexed keywords

ERYTHROPOIETIN; HEMOGLOBIN A1C; ICODEXTRIN;

ADULT; ARTICLE; BODY MASS; CAUSE OF DEATH; CHRONIC PERITONEAL DIALYSIS; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; CONTROL GROUP; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIABETIC PATIENT; FEMALE; FOLLOW UP; HEMOGLOBIN BLOOD LEVEL; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIPLE LINEAR REGRESSION ANALYSIS; NONDIABETIC PATIENT; PERITONEAL DIALYSIS; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; RISK FACTOR; UNIVERSITY HOSPITAL;

ADULT; AGE FACTORS; BODY MASS INDEX; CROSS-SECTIONAL STUDIES; DIALYSIS SOLUTIONS; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; LINEAR MODELS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; MORTALITY; PERITONEAL DIALYSIS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 78149291852     PISSN: 02508095     EISSN: None     Source Type: Journal    
DOI: 10.1159/000321899     Document Type: Article

References (32)

1. Brownlee M: Lilly Lecture 1993. Glycation and diabetic complications. Diabetes 1994; 43: 836-841.
2. Warram JH, Manson JE, Krolewski AS: Glycosylated hemoglobin and the risk of retinopathy in insulin-dependent diabetes mellitus. N Engl J Med 1995; 332: 1305-1306.
3. The effect of intensive treatment of diabetes on the development and progression of longterm complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. N Engl J Med 1993; 329: 977-986.
4. Edelman D, Olsen MK, Dudley TK, Harris AC, Oddone EZ: Utility of hemoglobin A1c in predicting diabetes risk. J Gen Intern Med 2004; 19: 1175-1180.
5. Droumaguet C, Balkau B, Simon D, Caces E, Tichet J, Charles MA, Eschwege E: Use of HbA1c in predicting progression to diabetes in French men and women: data from an Epidemiological Study on the Insulin Resistance Syndrome (DESIR). Diabetes Care 2006; 29: 1619-1625.
6. Selvin E, Coresh J, Golden SH, Brancati FL, Folsom AR, Steffes MW: Glycemic control and coronary heart disease risk in persons with and without diabetes: the atherosclerosis risk in communities study. Arch Intern Med 2005; 165: 1910-1916. (Pubitemid 41352087)
7. Khaw KT, Wareham N, Bingham S, Luben R, Welch A, Day N: Association of hemoglobin A1c with cardiovascular disease and mortality in adults: the European prospective investigation into cancer in Norfolk. Ann Intern Med 2004; 141: 413-420.
8. Selvin E, Steffes MW, Zhu H, Matsushita K, Wagenknecht L, Pankow J, Coresh J, Brancati FL: Glycated hemoglobin, diabetes, and cardiovascular risk in nondiabetic adults. N Engl J Med 2010; 362: 800-811.
9. Little RR, Tennill AL, Rohlfing C, Wiedmeyer HM, Khanna R, Goel S, Agrawal A, Madsen R, Goldstein DE: Can glycohemoglobin be used to assess glycemic control in patients with chronic renal failure? Clin Chem 2002; 48: 784-786.
10. Inaba M, Okuno S, Kumeda Y, Yamada S, Imanishi Y, Tabata T, Okamura M, Okada S, Yamakawa T, Ishimura E, Nishizawa Y: Glycated albumin is a better glycemic indicator than glycated hemoglobin values in hemodialysis patients with diabetes: effect of anemia and erythropoietin injection. J Am Soc Nephrol 2007; 18: 896-903.
11. Morioka T, Emoto M, Tabata T, Shoji T, Tahara H, Kishimoto H, Ishimura E, Nishizawa Y: Glycemic control is a predictor of survival for diabetic patients on hemodialysis. Diabetes Care 2001; 24: 909-913.
12. Kalantar-Zadeh K, Kopple JD, Regidor DL, Jing J, Shinaberger CS, Aronovitz J, McAllister CJ, Whellan D, Sharma K: A1c and survival in maintenance hemodialysis patients. Diabetes Care 2007; 30: 1049-1055.
13. Oomichi T, Emoto M, Tabata T, Morioka T, Tsujimoto Y, Tahara H, Shoji T, Nishizawa Y: Impact of glycemic control on survival of diabetic patients on chronic regular hemodialysis: a 7-year observational study. Diabetes Care 2006; 29: 1496-1500.
14. Williams ME, Lacson E Jr, Teng M, Ofsthun N, Lazarus JM: Hemodialyzed type I and type II diabetic patients in the US: characteristics, glycemic control, and survival. Kidney Int 2006; 70: 1503-1509.
15. Ishimura E, Okuno S, Kono K, Fujino-Kato Y, Maeno Y, Kagitani S, Tsuboniwa N, Nagasue K, Maekawa K, Yamakawa T, Inaba M, Nishizawa Y: Glycemic control and survival of diabetic hemodialysis patients - importance of lower hemoglobin A1c levels. Diabetes Res Clin Pract 2009; 83: 320-326.
16. Matsumae T, Abe Y, Murakami G, Ueda K, Saito T: Effects of glucose metabolism on aortic pulse wave velocity in hemodialysis patients with and without diabetes. Hypertens Res 2008; 31: 1365-1372.
17. Matsumae T, Abe Y, Murakami G, Ishihara M, Ueda K, Saito T: Determinants of arterial wall stiffness and peripheral artery occlusive disease in nondiabetic hemodialysis patients. Hypertens Res 2007; 30: 377-385.
18. Szeto CC, Chow KM, Kwan BC, Chung KY, Leung CB, Li PK: New-onset hyperglycemia in nondiabetic chinese patients started on peritoneal dialysis. Am J Kidney Dis 2007; 49: 524-532.
19. Tzamaloukas AH, Hsi KC, Quintana BJ, Merlin TL, Avasthi PS: Glycosylated hemoglobin measured by affinity chromatography in diabetic and nondiabetic patients on long-term dialysis therapy. West J Med 1989; 150: 415-419.
20. Sung KC, Rhee EJ: Glycated haemoglobin as a predictor for metabolic syndrome in nondiabetic Korean adults. Diabet Med 2007; 24: 848-854.
21. Osei K, Rhinesmith S, Gaillard T, Schuster D: Is glycosylated hemoglobin A1c a surrogate for metabolic syndrome in nondiabetic, first-degree relatives of African-American patients with type 2 diabetes? J Clin Endocrinol Metab 2003; 88: 4596-4601.
22. Brimble KS, Walker M, Margetts PJ, Kundhal KK, Rabbat CG: Meta-analysis: peritoneal membrane transport, mortality, and technique failure in peritoneal dialysis. J Am Soc Nephrol 2006; 17: 2591-2598.
23. Chung SH, Heimburger O, Stenvinkel P, Wang T, Lindholm B: Influence of peritoneal transport rate, inflammation, and fluid removal on nutritional status and clinical outcome in prevalent peritoneal dialysis patients. Perit Dial Int 2003; 23: 174-183.
24. Menon V, Greene T, Pereira AA, Wang X, Beck GJ, Kusek JW, Collins AJ, Levey AS, Sarnak MJ: Glycosylated hemoglobin and mortality in patients with nondiabetic chronic kidney disease. J Am Soc Nephrol 2005; 16: 3411-3417. (Pubitemid 46179345)
25. Himmelfarb J, Stenvinkel P, Ikizler TA, Hakim RM: The elephant in uremia: oxidant stress as a unifying concept of cardiovascular disease in uremia. Kidney Int 2002; 62: 1524-1538.
26. McIntyre NJ, Chesterton LJ, John SG, Jefferies HJ, Burton JO, Taal MW, Fluck RJ, Mc- Intyre CW: Tissue-advanced glycation end product concentration in dialysis patients. Clin J Am Soc Nephrol 2010; 5: 51-55.
27. Festa A, D'Agostino R Jr, Tracy RP, Haffner SM: C-reactive protein is more strongly related to post-glucose load glucose than to fasting glucose in non-diabetic subjects: the Insulin Resistance Atherosclerosis Study. Diabet Med 2002; 19: 939-943.
28. Esposito K, Nappo F, Marfella R, Giugliano G, Giugliano F, Ciotola M, Quagliaro L, Ceriello A, Giugliano D: Inflammatory cytokine concentrations are acutely increased by hyperglycemia in humans: role of oxidative stress. Circulation 2002; 106: 2067-2072.
29. Lin-Tan DT, Lin JL, Wang LH, Wang LM, Huang LM, Liu L, Huang JY, Huang YL: Fasting glucose levels in predicting 1-year all-cause mortality in patients who do not have diabetes and are on maintenance hemodialysis. J Am Soc Nephrol 2007; 18: 2385-2391.
30. Port FK, Ashby VB, Dhingra RK, Roys EC, Wolfe RA: Dialysis dose and body mass index are strongly associated with survival in hemodialysis patients. J Am Soc Nephrol 2002; 13: 1061-1066.
31. Lowrie EG, Li Z, Ofsthun N, Lazarus JM: Body size, dialysis dose and death risk relationships among hemodialysis patients. Kidney Int 2002; 62: 1891-1897.
32. Yen TH, Lin JL, Lin-Tan DT, Hsu CW: Association between body mass and mortality in maintenance hemodialysis patients. Ther Apher Dial 2010; 14: 400-408.